Asset Manager

Updated:

Turquoise Health

Turquoise Health operates as a software and data company that standardizes the financial plumbing of American healthcare.

Turquoise Health

Turquoise Health operates as a software and data company that standardizes the financial plumbing of American healthcare. The firm’s platform ingests publicly mandated price-disclosure files, normalizes the data, and delivers it through workflow tools for contracting, compliance, and patient-facing price estimates. Customers include UNC Health, which used Turquoise to replace a fragmented contract process and reported saving roughly $2 million in a single negotiation while cutting merger analysis from two weeks to one day. The company addresses the full revenue-cycle stack: provider rate-setting, payer network management, and direct-to-patient price-comparison tools. In 2025, Turquoise partnered with New York City to launch the NYC Health Care Price Comparison Tool, bringing machine-readable pricing to a municipal population. The firm also tracks federal rulemaking — the February 2026 Transparency in Coverage proposed rule aims to make hospital price files more usable, directly expanding the data surface Turquoise commercializes. Geographic coverage follows the US hospital and payer market, with a focus on large health systems and state-level transparency initiatives. Turquoise is venture-backed, with investors the firm describes as having built category-defining technology companies. The company is actively hiring across functions. Its go-to-market narrative stresses replacing the industry's $265 billion in annual administrative expense — a figure the Centers for Medicare & Medicaid Services has cited in national health expenditure analyses — with automated, predictable transactions. Turquoise’s structural differentiator is its position as a pure-play data refinery for regulatory price transparency. The 2021 Hospital Price Transparency rule generated millions of machine-readable files in inconsistent formats; Turquoise’s business scales with each new federal or state mandate that expands the corpus of computable pricing data. The company treats compliance not as a cost center but as an input to a proprietary pricing engine, giving it an information advantage that legacy clearinghouses and revenue-cycle vendors cannot replicate without rearchitecting their core systems.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Corporate office

Sector focus

Digital HealthEnterprise Software

Frequently asked questions

How does Turquoise Health obtain its pricing data?

Turquoise ingests publicly disclosed hospital and payer price-transparency files mandated by federal rules. The company normalizes these inconsistent machine-readable files into a uniform data model that customers query for rate comparisons, contract negotiations, and patient estimates. New regulatory proposals, such as the February 2026 Transparency in Coverage rule, could expand the scope and usability of the underlying data.

Does Turquoise Health operate as a healthcare provider or a software company?

Turquoise operates as a software and data infrastructure company. It does not deliver clinical care or process claims. The platform provides analytics and workflow tools that sit between providers, payers, and patients — helping each party access the pricing intelligence generated by price-transparency regulations.

What types of organizations use Turquoise Health's platform?

Turquoise counts 300-plus organizations as customers, including health systems, health plans, employers, and state governments. The company publicly cites UNC Health as a client and partnered with New York City to build the NYC Health Care Price Comparison Tool. Use cases range from managed-care contracting and compliance to patient-facing price estimates.

Is Turquoise Health profitable or purely venture-funded?

Turquoise has not publicly disclosed profitability. The company is venture-backed and actively hiring, which is typical of growth-stage enterprise software firms. It generates revenue through platform subscriptions tied to pricing, contracting, and compliance workflows.

What is Turquoise Health's relationship with federal transparency regulation?

Turquoise is a direct beneficiary of federal price-transparency mandates. The 2021 Hospital Price Transparency rule and subsequent insurer transparency rules generate the raw data the platform processes. Turquoise participates in the regulatory conversation — for example, commenting on the February 2026 proposed rule that aims to make price files more standardized and usable.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo